The European Voice of the Patient living with pulmonary hypertension associated with interstitial lung disease: Diagnosis, symptoms, impacts, and treatments

Documents similaires

• Screening and diagnosis of pulmonary hypertension associated with chronic lung disease (PH‐CLD): A consensus statement from the pulmonary vascular research institute's innovative drug development initiative—group 3 pulmonary hypertension
  par: P. Vitulo, et autres
  Publié: (2024)
• Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension
  par: Oksana A. Shlobin, et autres
  Publié: (2024)
• Pulmonary vascular disease, environmental pollution, and climate change
  par: Mona Lichtblau, et autres
  Publié: (2024)
• Severe pulmonary hypertension due to combined pulmonary fibrosis and emphysema: another cause of death among smokers
  par: André Carramenha de Góes Hirano
  Publié: (2017)
• Predictors of early mortality after lung transplantation for idiopathic pulmonary arterial hypertension
  par: Reda E. Girgis, et autres
  Publié: (2024)